Literature DB >> 23805337

Endovascular techniques in limb salvage: cutting, cryo, brachy, and drug-eluting balloons.

Mark G Davies1, Javier E Anaya-Ayala.   

Abstract

The complex pathophysiology response to injury of the lower-extremity arteries has prompted the development of several unique balloon technologies to overcome initial technical failures and short-term intimal hyperplasia. Cryoplasty alters the cellular and mechanical properties of the vessel wall during angioplasty. Cutting balloons incise the wall, preventing elastic recoil and allowing expansion of the lumen at a lower pressure, thus limiting barotrauma. Drug-eluting balloons actively transfer inhibitory compounds to the wall during the initial therapy, while brachytherapy balloons allow for localized delivery of radiation to inhibit the proliferative response seen after angioplasty. These platforms provide unique means to enhance immediate and short-term results and also reduce stent usage in the lower extremity.

Entities:  

Keywords:  balloon angioplasty; brachytherapy balloon; critical limb ischemia; cryoplasty; cutting balloon; drug-eluting balloon; lower extremity intervention; percutaneous transluminal angioplasty; restenosis

Mesh:

Substances:

Year:  2013        PMID: 23805337      PMCID: PMC3693518          DOI: 10.14797/mdcj-9-2-69

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  34 in total

1.  Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty : results of a prospective randomized study.

Authors:  E Minar; B Pokrajac; T Maca; R Ahmadi; C Fellner; M Mittlböck; W Seitz; R Wolfram; R Pötter
Journal:  Circulation       Date:  2000-11-28       Impact factor: 29.690

2.  Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT).

Authors:  Remo Albiero; Sigmund Silber; Carlo Di Mario; Carmelo Cernigliaro; Salvatore Battaglia; Bernhard Reimers; Arian Frasheri; Volker Klauss; Joseph M Auge; Paolo Rubartelli; Marie-Claude Morice; Alberto Cremonesi; Joachim Schofer; Alessandro Bortone; Antonio Colombo
Journal:  J Am Coll Cardiol       Date:  2004-03-17       Impact factor: 24.094

Review 3.  Local paclitaxel delivery for treatment of peripheral arterial disease.

Authors:  Beau M Hawkins; Thomas A Hennebry
Journal:  Circ Cardiovasc Interv       Date:  2011-05-03       Impact factor: 6.546

4.  Endovascular brachytherapy for prophylaxis against restenosis after long-segment femoropopliteal placement of stents: initial results.

Authors:  R M Wolfram; B Pokrajac; R Ahmadi; C Fellner; M Gyöngyösi; M Haumer; R Bucek; R Pötter; E Minar
Journal:  Radiology       Date:  2001-09       Impact factor: 11.105

5.  Cutting balloon percutaneous transluminal angioplasty for salvage of lower limb arterial bypass grafts: feasibility.

Authors:  Christoph Engelke; Robert A Morgan; Anna-Maria Belli
Journal:  Radiology       Date:  2002-04       Impact factor: 11.105

6.  Gamma radiation induces positive vascular remodeling after balloon angioplasty: a prospective, randomized intravascular ultrasound scan study.

Authors:  T Hagenaars; I F Lim A Po; M R H M van Sambeek; V L M A Coen; R B M Van Tongeren; F M Gescher; C H A Wittens; R U Boelhouwer; P M T Pattynama; E J Gussenhoven
Journal:  J Vasc Surg       Date:  2002-08       Impact factor: 4.268

7.  Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging.

Authors:  Rolf Wyttenbach; Augusto Gallino; Mario Alerci; Felix Mahler; Luca Cozzi; Marcello Di Valentino; Juan J Badimon; Valentin Fuster; Roberto Corti
Journal:  Circulation       Date:  2004-08-23       Impact factor: 29.690

8.  Early outcome of "cutting" balloon angioplasty for infrainguinal vein graft stenosis.

Authors:  Karthikeshwar Kasirajan; Peter A Schneider
Journal:  J Vasc Surg       Date:  2004-04       Impact factor: 4.268

9.  Endovascular gamma irradiation of femoropopliteal de novo stenoses immediately after PTA: interim results of prospective randomized controlled trial.

Authors:  Karsten Krueger; Peter Landwehr; Mark Bendel; Monika Nolte; Hartmut Stuetzer; Rudolf Bongartz; Markus Zaehringer; Guido Winnekendonk; Axel Gossmann; Rolf-Peter Mueller; Klaus Lackner
Journal:  Radiology       Date:  2002-08       Impact factor: 11.105

10.  Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia.

Authors:  Gary M Ansel; Nancy S Sample; Charles F Botti III; Amy J Tracy; Mitchell J Silver; Brian J Marshall; Barry S George
Journal:  Catheter Cardiovasc Interv       Date:  2004-01       Impact factor: 2.692

View more
  5 in total

Review 1.  Intravascular brachytherapy for peripheral vascular disease.

Authors:  Alina Andras; Monica Hansrani; Marlene Stewart; Gerard Stansby
Journal:  Cochrane Database Syst Rev       Date:  2014-01-08

Review 2.  When Are Endovascular and Open Bypass Treatments Preferred for Femoropopliteal Occlusive Disease?

Authors:  Ali F AbuRahma
Journal:  Ann Vasc Dis       Date:  2018-03-25

3.  Lin28a up-regulation is associated with the formation of restenosis via promoting proliferation and migration of vascular smooth muscle cells.

Authors:  Zhiwei Zou; Xiaojun Zhou; Ruzhen Zhang; Qian Zhang; Shan Jiang; Chunmei Xu; Rui Zhang; Tianyue Xie; Huangao Zhu; Piyun Gong; Dongmei Zhang; Huimei Ma; Lin Liao; Jianjun Dong
Journal:  J Cell Mol Med       Date:  2020-07-25       Impact factor: 5.310

4.  Endovascular balloon angioplasty for infrainguinal arterial occlusive disease: Efficacy analysis.

Authors:  Mehmet Cahit Sarıcaoğlu; Bahadır Aytekin; Görkem Yiğit; Anıl Özen; Hakkı Zafer İşcan
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-01-13       Impact factor: 0.332

5.  Cilostazol as a noninferiority pharmacologic option to paclitaxel in early intimal hyperplasia inhibition after venous balloon angioplasty in a rabbit model: a preliminary study.

Authors:  Rodrigo Lozano-Corona; Hugo Laparra-Escareno; Javier E Anaya-Ayala; Alejandro Zentella-Dehesa; Jesus J Baquera-Heredia; Ruben Argüero-Sánchez; Carlos A Hinojosa
Journal:  JVS Vasc Sci       Date:  2020-10-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.